|
The document is a Chain of Custody and Analysis Request Form from Weston Solutions, Inc. for soil samples collected in Decatur, AL, indicating the analysis of perfluorinated compounds, specifically PFOA and PFOS, with multiple soil depths specified for testing.
|
— |
AR226-3828
|
QX2ngyQ9BXjzbpM9VLYgKOV37 |
57 |
|
This document is a chain of custody and analysis request form from Weston Solutions, Inc. for soil samples collected in Decatur, AL, indicating the need for analysis related to the FSIA GP Investigation.
|
— |
AR226-3828
|
kavVj4V0y1enRvkae4VV1JoVO |
14 |
|
This is a Severn Trent Laboratories analytical report (Project No. 26000) prepared for Weston Solutions, detailing the analytical results for samples received on October 18, 2006, including documentation of sample condition and adherence to quality control criteria.
|
— |
AR226-3828
|
2JDbwGaVv3baanVrQG01keqzg |
46 |
|
The document is a summary package from Severn Trent Laboratories detailing the analytical results for various tissue samples received on October 18, 2006, under Laboratory Project No. 26000, but does not specify any findings related to PFOA or PFOS.
|
— |
AR226-3828
|
yrNY5dDMX6r5O0RE6mR4R5Jy4 |
32 |
|
This is a Severn Trent Laboratories analytical report (Project No. 26000) prepared for Weston Solutions, detailing the analytical results for samples received on October 18, 2006, including a summary of sample handling and quality control.
|
— |
AR226-3828
|
jm45pLB9ddmVZBnVa3kvQG8nO |
47 |
|
The document is a summary package of analytical results for various tissue samples received by Severn Trent Laboratories in Burlington, Vermont, on October 18, 2006, related to Laboratory Project No. 26000, but does not specify findings regarding PFOA or PFOS.
|
— |
AR226-3828
|
3amNqnzXdqrqM37Nj8X81ZeE |
35 |
|
This is a Severn Trent Laboratories analytical report (Project No. 26000) prepared for Weston Solutions, detailing the analytical results for samples received on October 18, 2006, including documentation of sample handling and quality control.
|
— |
AR226-3828
|
zQ2dZYQOJo3ZZpgYz7QgV6QJz |
40 |
|
The document is a summary package from Severn Trent Laboratories detailing the analytical results for various tissue samples received on October 18, 2006, under Laboratory Project No. 26000, but does not specify any findings related to PFOA or PFOS.
|
— |
AR226-3828
|
1xOjzMbLZn8BVM782p06XY0E |
29 |
|
This is a Severn Trent Laboratories analytical report (Project No. 26000, SDG: 117632) prepared for Weston Solutions, detailing the results of tissue samples received on October 18, 2006, along with a chain of custody and sample handling documentation.
|
— |
AR226-3828
|
8Vm1kREej2yzoeVvw1o6nNmVy |
49 |
|
The document provides a summary of analytical results for various tissue samples related to Laboratory Project No. 26000, received by Severn Trent Laboratories on October 18, 2006, but does not specify any findings related to PFOA or PFOS.
|
— |
AR226-3828
|
gDo2y6MXpbLbzNZ3bM4LDkojN |
38 |
|
This is a Severn Trent Laboratories analytical report (Project No. 26000) prepared for Weston Solutions, detailing the analytical results for samples received on October 18, 2006, including documentation of sample handling and quality control.
|
— |
AR226-3828
|
NEL7a0VJGB6392J2nVD44qYBg |
36 |
|
This document is a summary package of analytical results for various tissue samples analyzed by Severn Trent Laboratories in Burlington, Vermont, related to laboratory project number 26000 and sample delivery group 117633.
|
— |
AR226-3828
|
MMje0XGkp4Ek9jbo7J0o0dRJ7 |
24 |
|
This is a Severn Trent Laboratories analytical report (Project No. 26000, SDG: 117702) prepared for Weston Solutions, detailing the analytical results for tissue samples received on November 17, 2006.
|
— |
AR226-3828
|
da6vqdp5BBn3jM2eVYaMO2Y1R |
47 |
|
The document is a summary of analytical results for tissue samples received by Severn Trent Laboratories in Burlington, Vermont, on November 17, 2006, with no exceptions noted to the method quality control criteria during the analyses.
|
— |
AR226-3828
|
J3Ox087gznYy75Q5g4dvo47qv |
35 |
|
This internal correspondence details the results of pooled human serum samples for PFOS collected from European blood banks in 1999, showing consistent findings with previous data, with average concentrations of PFOS in Belgium, the Netherlands, and Germany being 17 ppb, 53 ppb, and 37 ppb, respectively.
|
— |
AR226-0646
|
82bO40opB9VLk3R7pOoGpMyxB |
2 |
|
The document discusses the results of skin and eye irritation assessments conducted on FC-95 (T-1117), a product containing PFOS, by the WARF Institute, indicating it was non-irritating to skin but minimally to mildly irritating to eyes, with recommendations for precautionary labeling.
|
— |
AR226-0647
|
byzGLV7rnGbw0EXqM5XgDvZk |
8 |
|
The document is a final report from SRI International examining the mutagenic activity of 3M Company's Compound T-2816CoC (related to PFOS) using in vitro microbiological assays, which concluded that the compound was not mutagenic or recombinogenic in any of the tests performed.
|
— |
AR226-0648
|
GmeL8b4wVKeXb1edKy67wRdrN |
15 |
|
The document is a final report from SRI International assessing the mutagenic activity of 3M Company's Compound T-2997CoC (related to PFOS) using the Ames Salmonella/microsome assay and yeast assays, concluding that the compound was not mutagenic or recombinogenic in any tests performed.
|
— |
AR226-0649
|
mB432Bv0dKbY6rJ7rd5RO11bd |
18 |
|
The document is a draft electron microscopy report detailing the findings from a 26-week toxicity study of perfluorooctane sulfonic acid (PFOS) in cynomolgus monkeys, indicating that liver lesions observed during treatment have resolved in recovery animals.
|
— |
AR226-0650
|
Y7NmMpOom7L5ML0nMvvQmo3O |
35 |
|
This document reports on a 6-month study of PFOS conducted on cynomolgus monkeys for 3M, detailing various biochemical parameters such as TSH, cholesterol, and lipoprotein levels across different groups.
|
— |
AR226-0651
|
zMvw7GR9BY12xZkGgYM9xz8z |
12 |
|
A 28-day percutaneous absorption study of FC-98, a substance containing PFOS, was conducted on albino rabbits at Riker Laboratories, which indicated dermal absorption but lacked conclusive results due to limited sample analysis.
|
— |
AR226-0653
|
2qro19LXLe6reEZppQBKDZ1Jb |
17 |
|
The document is a final report of a single-dose intravenous pharmacokinetic study of T-6684, a compound related to PFOS, conducted by Corning Hazleton Inc. for 3M, detailing the study's context, quality assurance, and completion date.
|
— |
AR226-0654
|
DD4NXzjdM796kaeqzzN3xkpMN |
37 |
|
This document outlines a pharmacokinetic study of perfluorooctane sulfonyl fluoride (POSF) in male Sprague Dawley rats to assess its oral absorption, clearance, and metabolism to perfluorooctane sulfonate (PFOS), conducted by 3M Chemicals Division under GLP conditions.
|
— |
AR226-0656
|
dYd8NpR0L3x7MR4jm3DN4r55Q |
8 |
|
This master's thesis by Deanna J. Nabbefeld investigates the effects of perfluorooctane sulfonic acid (PFOS) and other fluorocarbons on liver fatty acid-binding protein (L-FABP), finding that PFOS significantly decreases the maximum binding capacity of L-FABP in treated rats.
|
— |
AR226-0652
|
4v7R6b5GL0QwKE9mq9jkbG7mQ |
56 |
|
This document is a final report from Covance Laboratories Inc. detailing a 5-daily dose dermal absorption/toxicity study of the substance T-6684, sponsored by 3M, conducted on rabbits, with a completion date of December 31, 1997.
|
— |
AR226-0655
|
B54vr1GMDLkKxBQ7JMyBL0pQw |
54 |
|
This document reports on an acute oral toxicity study of the substance FM-3422, produced by 3M Company, which determined the LD50 values in male and female rats to be 1615 mg/kg and 1333 mg/kg, respectively.
|
— |
AR226-0657
|
Z44VVK7djDQbDZdBjXG9rqN17 |
14 |
|
The document reports on a study conducted by Riker Laboratories, Inc. that identified a major metabolite, 2-N-ethyl perfluorooctanesulfonamido acetic acid (PFSAA), from the feces of rats after they were administered a carbon-14 labeled N-ethyl FOSE in feed for one week, with the metabolite accounting for at least 50
|
— |
AR226-0658
|
0qRBEpp35Rze0jEo4R73nEm3R |
22 |
|
The document outlines a rat teratology study protocol to assess the embryo/fetal toxicity and teratogenic potential of a test material, identified as T-3352, administered to pregnant rats, in compliance with FDA guidelines.
|
— |
AR226-0661
|
bZvbKyXVqy4R0MkyxjL3prg3 |
14 |
|
The document reports on an acute oral toxicity study of the substance T-306700C conducted on albino rats, finding that the approximate oral LD50 is greater than 5,000 mg/kg, with no observed mortalities or adverse effects during the observation period.
|
— |
AR226-0662
|
by5mz7G8o0x11mrbXKqQe0yk0 |
9 |
|
The document is a final report on a pilot rat teratology study conducted by Hazleton Laboratories America, Inc. for 3M Company, evaluating the effects of N-Et FOSE alcohol on maternal and fetal outcomes.
|
— |
AR226-0659
|
p06kZreM75Y6w5jkyQYZbKkD |
51 |
|
The document is a final report of a rat teratology study (Project No. 154-161) conducted by Hazleton Laboratories for 3M Company, focusing on the effects of N-Et FOSE alcohol, a perfluorinated compound, under Good Laboratory Practice regulations.
|
— |
AR226-0660
|
wZBNq85zBJ1xROKXd8x7wmzQ |
80 |
|
This document is a final report of a single-dose intravenous pharmacokinetic study of T-5904, a compound produced by 3M, conducted on rabbits by Hazleton Wisconsin, Inc.
|
— |
AR226-0663
|
LXnGJe4GNRdwn9gprk52jMdq |
25 |
|
The document is a final report from Hazleton Laboratories detailing an acute oral toxicity study of PFOA (sample T-4416) conducted on rats, following OECD guidelines, with a focus on methodology and results.
|
— |
AR226-0665
|
ByL6XL2eo5LkGNxaMMRbjenm |
23 |
|
The document is a final report from Hazleton Laboratories detailing an acute toxicity study on PFOA (sample T-4416) conducted on rabbits to assess primary dermal irritation/corrosion according to OECD guidelines.
|
— |
AR226-0666
|
Dv3zERBYagB02xrQ5K11KYL04 |
10 |
|
The document is a final report from Hazleton Laboratories assessing the acute ocular toxicity of PFOA (sample T-4416) in rabbits, following OECD guidelines.
|
— |
AR226-0667
|
BRLNoV95rZ79M9ygKBGrmZ1aJ |
18 |
|
The document is an analytical report from Centre Analytical Laboratories detailing the characterization of surface water samples collected from Mobile, Alabama, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-0673
|
kaEmZ8ODwzaJKkB72QgRDVpNJ |
8 |
|
This analytical report from Centre Analytical Laboratories details the fluorochemical characterization of surface water samples collected from Pensacola, FL, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-0674
|
ypn64Bg9xoVOJaNLMpOL7Kj5r |
8 |
|
This analytical report from Centre Analytical Laboratories details the fluorochemical characterization of surface water samples from Port St. Lucie, FL, specifically analyzing for perfluorooctane sulfonate (PFOS), perfluorooctane sulfonamide (PFOSA), and perfluorooctanoate (POAA) using liquid chromatography/tandem mass spectrometry (LC/MS/MS).
|
— |
AR226-0675
|
NRax1y2ybEzKDrGXE37ajExw |
6 |
|
The document outlines a pharmacokinetic study protocol by 3M to assess the oral absorption, clearance, and biological persistence of Perfluorooctane Sulfonamide (PFOSA) in rats, aiming to investigate its potential conversion to PFOS and improve risk characterization.
|
— |
AR226-0664
|
QM2gDO4bmxob5gao5GN7mVnz6 |
333 |
|
This interim report from 3M Environmental Laboratory analyzes perfluorobutanesulfonate (PFBS), perfluorohexanesulfonate (PFHS), and perfluorooctanesulfonate (PFOS) in various environmental samples as part of the 3M Decatur Monitoring Program, adhering to EPA TSCA Good Laboratory Practice Standards.
|
— |
AR226-3828
|
zbvG6M0aLoXRGZ5g8OK6VLpd0 |
123 |
|
The document reports on an acute toxicity test of a mixture containing perfluorooctanesulfonate (PFOS) on rainbow trout, indicating a 96-hour LC50 value greater than 400 mg/L, suggesting low toxicity at the tested concentrations.
|
— |
AR226-0715
|
mqgBzeqrOagxrzBEQbzZpMm9O |
4 |
|
The document reports on a biodegradation test of a mixture containing 0.92% perfluorooctanesulfonate (PFOS) conducted by Pace Laboratories for 3M Company, noting significant chemical oxygen demand (COD) and biochemical oxygen demand (BOD) results but lacking detailed methodology and conclusions.
|
— |
AR226-0806
|
EqR5bnMY10N3Xn27rkVx8R3VR |
5 |
|
The document reports that the 96-hour LC50 for a mixture containing 0.5% PFOS (FC-780) was greater than 5000 mg/L, indicating low acute toxicity to the fish species Fundulus heteroclitus.
|
— |
AR226-0869
|
ByQRjkvEd4BaGEMRnrkDKZwj |
3 |
|
The document reports on biodegradation studies of a mixture containing perfluorooctanesulfonate (PFOS) from 3M, indicating that while the majority of the product components are readily biodegradable, no reliable conclusions can be drawn regarding the degradation potential of the fluorochemical component.
|
— |
AR226-0870
|
6RqOBZvJm0j39ox5QDx3NgRLR |
36 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-0930
|
5L5drZooQJ6M6mjd2aD5L8rRR |
1 |
|
Unreadable document.
|
— |
AR226-0937
|
G6Go2dZ8EaYRQKD5MzZ2QrKDn |
2 |
|
The document outlines a meeting between the EPA and the Fluoropolymer Industry to discuss the safe manufacture and use of fluorinated processing aids (APFO/PFOA) in fluoropolymers, addressing industry practices, regulatory expectations, and environmental impacts.
|
— |
AR226-0938
|
ga1p5kzpbGO5kRy7JjQoEYaY3 |
7 |
|
Unreadable document.
|
— |
AR226-0939
|
bavzNeMzMda5ddkxQq40dNZd3 |
2 |
|
The document summarizes studies conducted by 3M on the foaming characteristics of their AFFF products containing PFOS, highlighting the impact of foaming on wastewater treatment processes and noting that the data lacks agency-approved procedures.
|
— |
AR226-0926
|
DGdzYDmpX3B40QVm5Reyq5wMM |
59 |
|
Unreadable document.
|
— |
AR226-0942
|
6B6nVQG8Zvo73w87wzb3GxJL9 |
1 |
|
Unreadable document.
|
— |
AR226-0944
|
q7XDnN40DOv4vk238Kz6dbrG |
2 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act.
|
— |
AR226-0994
|
e7zQ0Rb9QvazVqBX6NB7XDwKE |
1 |
|
This is a TSCA NCIC Notification Form indicating that the document contains confidential business information protected under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-0995
|
5LR69V83qo4XmJMMmKqkZVx4e |
1 |
|
Unreadable document.
|
— |
AR226-0999
|
K6q5Bbkdz9j2mKZk4ebMGNZxQ |
1 |
|
Unreadable document.
|
— |
AR226-1002
|
oo1GnZnDag4jJRV84D77x5Lo |
1 |
|
Unreadable document.
|
— |
AR226-1014
|
xjozYjnqzrmQvEnYdmYnn6q4b |
1 |
|
Chemguard Inc. submitted confidential information regarding their AFFF type foam concentrate, Chemguard FS-100, which contains a proprietary fluorochemical surfactant and is manufactured at 40% solids in water.
|
— |
AR226-1040
|
2jQrvndmyx0MZo122raexrw0N |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1071
|
Radp6e2vpzppaaaBJyLKn4J88 |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act.
|
— |
AR226-1119
|
nNaMGyy1M0qQ6z4Dw62Xm4pzz |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1118
|
3No4Ekwn6bJ9VYJG8MEVQyrbE |
1 |
|
Unreadable document.
|
— |
AR226-1142
|
ZJmpDK33vy4NxweVr5BZEnBDd |
1 |
|
This is a TSCA NCIC Notification Form related to confidential business information under the Toxic Substances Control Act, with no analytical content retained in the OCR.
|
— |
AR226-1214
|
gaOQ1wnnoDbYgOrd0r8ev37NG |
1 |
|
This is a TSCA NCIC Notification Form indicating that the document contains confidential business information protected under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1248
|
a1Qwm669nw923y4KKEKBO0oob |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document referenced by a docket number, emphasizing the protection of such information under TSCA regulations.
|
— |
AR226-1251
|
151NbMppgyn98X7KMnd9DqORX |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document control number 63.03, indicating the document is protected under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1249
|
vBgD9kj0Q9mqjep65GVL201kq |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act.
|
— |
AR226-1250
|
0q7ao7y7y7Dk6MMOqXBgVYkLM |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1252
|
dQXDkJnOvzDjGk7d9w2e531db |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document under the Toxic Substances Control Act, indicating that the information is protected from public disclosure.
|
— |
AR226-1254
|
JrwNDamYBnjm0XEBJxmYo2era |
1 |
|
Unreadable document.
|
— |
AR226-1253
|
w2GOx3rbXyDkZw1OL591z0RB |
1 |
|
This is a TSCA NCIC Notification Form with no analytical content retained in the OCR.
|
— |
AR226-1256
|
Byyve0dgYOD96d0Nroqm07pkL |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1255
|
2qVMXKpLeo49MNovjZgywRgGg |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1257
|
oeNnZrkNN6kyKgqp2Qnwxd90w |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document contains confidential business information protected under the Toxic Substances Control Act.
|
— |
AR226-1268
|
v6owXXG6pX198djnReg8Mq8ZR |
1 |
|
The document discusses voluntary actions taken by Asahi Glass Fluoropolymers USA to evaluate and control emissions of ammonium perfluorooctanoate (PFOA) at their Bayonne, New Jersey site.
|
— |
AR226-1269
|
6RkjwBJ6Gje0wD32aGq8nEqyR |
1 |
|
This document appears to be a summary of various toxicity studies and analyses related to telomer manufacturing processes, including acute and chronic toxicity tests, biodegradation studies, and physicochemical properties, with references to reports and protocols from DuPont.
|
— |
AR226-1293
|
M4Qz35pgBywOOvzwzq382eXOa |
1 |
|
Unreadable document.
|
— |
AR226-1296
|
gkg97xRBXK4dZM6ZvQOQDMrV |
1 |
|
Unreadable document.
|
— |
AR226-1297
|
daeweB1Ry4Do5899wMOn772xG |
1 |
|
Unreadable document.
|
— |
AR226-1301
|
M4RGO9gDz2Oz8abp89vVp4oDV |
2 |
|
The document discusses the mechanics of film formation in Aqueous Film-Forming Foam (AFFF), highlighting the role of hydrocarbon and fluorocarbon surfactants in creating an effective fuel vapor barrier and enhancing fire extinguishing efficiency through spontaneous spreading properties.
|
— |
AR226-1314
|
3NZ5qmwX7eVRwqG7jno40J8zn |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to PFOA/PFOS, emphasizing the protection of such information under the Toxic Substances Control Act.
|
— |
AR226-1320
|
p705krodEy72NZxGEN5EgRDB |
1 |
|
The document presents water quality data from various locations near Parkersburg, West Virginia, indicating levels of PFOA (C-8) detected in water samples collected on March 15, 1984, and June 4, 1984, with some sites reporting values below the detection limit.
|
— |
AR226-1409
|
3NVVoyMnbVp8B266MeKo8wGXy |
1 |
|
The document reports on sampling results for perfluorooctanoic acid (PFOA, referred to as C-8) in various water taps and private wells in Lubeck, with CH2MHILL confirming its presence in some samples.
|
— |
AR226-1411
|
a41jdx0aqEyNjVEpjjBkK6q6X |
1 |
|
This is a letterhead cover page from an unspecified laboratory, with no analytical content retained in the OCR.
|
— |
AR226-1412
|
3QwO8YMyXg2zj858KaYDoEeYJ |
1 |
|
Unreadable document.
|
— |
AR226-1414
|
1p7y7aZa986nbMeOYe08OkQd |
1 |
|
This is a TSCA NCIC Notification Form related to confidential business information, with no analytical content retained in the OCR.
|
— |
AR226-1434
|
MGjqJJM34q8j5wnX3w436NDnk |
1 |
|
This is a letterhead cover page from an unspecified organization, with no analytical content retained in the OCR.
|
— |
AR226-1435
|
vkvM9RzxLqrrwnvEzDaaRkR |
1 |
|
This is a TSCA NCIC Notification Form regarding confidential business information (CBI) related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1436
|
4m9ydY7onaDLBrv60Er7dExa |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act.
|
— |
AR226-1438
|
qao7ky6Ya513XwbEx8Yz7EJL5 |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information related to a document under the Toxic Substances Control Act, with no analytical content retained in the OCR.
|
— |
AR226-1437
|
vBwY4oNkgELY4YJYzNMNo8q4q |
1 |
|
This is a letterhead cover page indicating that the document is claimed as confidential business information under TSCA, with no analytical content retained in the OCR.
|
— |
AR226-1479
|
jmm0yqvkV6G439GE7nKBGVEZp |
1 |
|
Unreadable document.
|
— |
AR226-1480
|
VGbn4y19XRNm8aBO9Qz1reKNg |
1 |
|
This is a TSCA NCIC Notification Form for confidential business information documents, with no analytical content retained in the OCR.
|
— |
AR226-1481
|
daGj5p2Qd6e14J22EeLGzg3qe |
1 |
|
This is a figure from a RCRA Facility Investigation report detailing sampling locations at the 3M Decatur site in Morgan County, Alabama.
|
— |
AR226-1484
|
Z4Q95wGXKO8d2rbpX0vok5xrO |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under TSCA, with details regarding access and penalties for unauthorized disclosure.
|
— |
AR226-1487
|
32jr9NozbndQ66wNM0D11x8x |
1 |
|
Unreadable document.
|
— |
AR226-1488
|
qaR36Bw9ewLDJ42jZyj8rqyjx |
2 |
|
Unreadable document.
|
— |
AR226-1513
|
DD17bvxO2kZZMQgGGKnvK1M0d |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under the Toxic Substances Control Act.
|
— |
AR226-1514
|
pmY90OLQoYEj4n6gYwG3EQvrj |
1 |
|
This is a TSCA NCIC Notification Form regarding confidential business information (CBI) related to a document claimed under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1515
|
zbzoQG2OY4NOnz8q5GrDZ96Em |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under TSCA regulations.
|
— |
AR226-1537
|
1gYwRRRbbbBBx5yY19VoYBEEZ |
1 |
|
This is a TSCA NCIC Notification Form indicating that the referenced document is claimed as confidential business information under Section 14 of the Toxic Substances Control Act.
|
— |
AR226-1543
|
6bG5owakxxypGxV76gQ2pnmOm |
1 |